🟢 Painreform is trading 8.39% up today amid broader biotech gains

Painreform is trading at $0.78, up 8.39%, with a biotech sector rally offering a possible supporting context.

• No new company-specific announcement was identified for October 21, 2026; Painreform’s investor-relations page lists its latest releases as September 16 and September 9.
• The supplied sector update reports XBI up 2.10%, citing acquisition activity and positive clinical-trial news.
• Painreform’s gain exceeds the sector advance; no company-specific catalyst or trading-volume figure is confirmed.